By Dr. Sanchari Sinha Dutta, Ph.D.Reviewed by Danielle Ellis, B.Sc. Serum samples obtained from the recipients of the BriLife® coronavirus disease 2019 (COVID-19) vaccine candidate have shown high potency in neutralizing the alpha, beta, gamma, and delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human sera. Image Credit:...
